Amy Schulman

Amy Schulman

Vermogen: 5 M $ op 31-07-2026

65 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Amy L.
Schulman
founded Lyndra Therapeutics, Inc. in 2015, where she is working as Executive Chairman from 2019 and LS Polaris Innovation Fund in 2017, where she is working as Managing Partner from 2017.
Ms. Schulman also founded Suono Bio, Inc., where she worked as Executive Chairman.
Ms. Schulman also currently works at SQZ Biotechnologies Co., as Chairman from 2015, Alnylam Pharmaceuticals, Inc., as Chairman from 2023, Elevance Health, Inc., as Independent Director from 2026, and various other companies.
Ms. Schulman also formerly worked at Eagle Biologics, Inc., as Chief Executive Officer from 2014 to 2016, Olivo Laboratories LLC, as Executive Chairman & Chief Executive Officer, Fractyl Health, Inc., as Independent Director from 2018 to 2025, and various other companies.
Ms. Schulman received her undergraduate degree from Wesleyan University and graduate degree in 1989 from Yale Law School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
20-05-2026 23.211 ( 0,02% ) 5 M $ 31-07-2026
13-05-2026 781 ( 0% ) 293 531 $ 31-07-2026

Actieve functies van Amy Schulman

BedrijvenFunctieBegin
ALNYLAM PHARMACEUTICALS, INC. Voorzitter 05-01-2023
SQZ BIOTECHNOLOGIES COMPANY Voorzitter 01-07-2015
HUDSON EXECUTIVE INVESTMENT CORP. II Directeur/Bestuurslid 25-01-2021
ELEVANCE HEALTH, INC. Directeur/Bestuurslid 12-01-2026
Directeur/Bestuurslid -
Directeur/Bestuurslid 20-11-2019
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Amy Schulman

BedrijvenFunctieEinde
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Ervaring van Amy Schulman in detail bekijken

Opleiding van Amy Schulman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

84

Eerstegraads connecties

45

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit45

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Producer Manufacturing

Health Technology

Health Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Consumer Non-Durables

Consumer Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Health Services

Health Technology

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. Amy Schulman